Form 4 Tracker
Frank E Thomas

Director · 1 filing · Latest: Feb 27, 2026

Larimar Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LRMR
Frank E ThomasDirectorFeb 27, 2026
Purchase
$5.005,000$25.0K7,000